| Nanoparticle-based delivery systems for vaccines R Bezbaruah, VP Chavda, L Nongrang, S Alom, K Deka, T Kalita, F Ali, ... Vaccines 10 (11), 1946, 2022 | 62 | 2022 |
| Replicating viral vector-based vaccines for COVID-19: potential avenue in vaccination arena VP Chavda, R Bezbaruah, M Athalye, PK Parikh, AS Chhipa, S Patel, ... Viruses 14 (4), 759, 2022 | 54 | 2022 |
| The Delta and Omicron variants of SARS-CoV-2: what we know so far VP Chavda, R Bezbaruah, K Deka, L Nongrang, T Kalita Vaccines 10 (11), 1926, 2022 | 51 | 2022 |
| Fast-track development of vaccines for SARS-CoV-2: the shots that saved the world VP Chavda, Q Yao, LK Vora, V Apostolopoulos, CA Patel, R Bezbaruah, ... Frontiers in Immunology 13, 961198, 2022 | 46 | 2022 |
| Adenoviral vector-based vaccine platform for COVID-19: Current status VP Chavda, R Bezbaruah, D Valu, B Patel, A Kumar, S Prasad, BB Kakoti, ... Vaccines 11 (2), 432, 2023 | 36 | 2023 |
| COVID-19 and vaccination: myths vs science VP Chavda, Y Chen, J Dave, ZS Chen, SC Chauhan, MM Yallapu, ... Expert Review of Vaccines 21 (11), 1603-1620, 2022 | 34 | 2022 |
| Developmental landscape of potential vaccine candidates based on viral vector for prophylaxis of COVID-19 R Bezbaruah, P Borah, BB Kakoti, NA Al-Shar’I, B Chandrasekaran, ... Frontiers in Molecular Biosciences 8, 635337, 2021 | 31 | 2021 |
| Advanced phytochemical-based nanocarrier systems for the treatment of breast cancer VP Chavda, LV Nalla, P Balar, R Bezbaruah, V Apostolopoulos, ... Cancers 15 (4), 1023, 2023 | 23 | 2023 |
| Convalescent plasma (hyperimmune immunoglobulin) for COVID-19 management: An update VP Chavda, R Bezbaruah, S Dolia, N Shah, S Verma, S Savale, S Ray Process Biochemistry 127, 66-81, 2023 | 21 | 2023 |
| CAR T-Cell therapy for the management of mantle cell lymphoma Z Huang, VP Chavda, R Bezbaruah, H Dhamne, DH Yang, HB Zhao Molecular Cancer 22 (1), 67, 2023 | 21 | 2023 |
| An ayurgenomics approach: prakriti-based drug discovery and development for personalized care Z Huang, VP Chavda, R Bezbaruah, VN Uversky, S P, AB Patel, ZS Chen Frontiers in Pharmacology 13, 866827, 2022 | 17 | 2022 |
| Therapeutic drug repositioning with special emphasis on neurodegenerative diseases: Threats and issues BB Kakoti, R Bezbaruah, N Ahmed Frontiers in Pharmacology 13, 1007315, 2022 | 11 | 2022 |
| Engineered exosomes for cancer theranostics: Next-generation tumor targeting VP Chavda, VV Sugandhi, CV Pardeshi, RJ Patil, M Joshi, BM Patel, ... Journal of Drug Delivery Science and Technology, 104579, 2023 | 8 | 2023 |
| Rosa alba Linn.: a comprehensive review on plant profile, phytochemistry, traditional and pharmacological uses S Alom, F Ali, R Bezbaruah, BB Kakoti World Journal of Pharmaceutical Research 10 (4), 798-811, 2021 | 6 | 2021 |
| Entada Phaseoloides Attenuates Scopolamine-induced Impairment of Spatial Memory in Mice. CC Barua, L Buragohain, B Saikia, B Siva, GS Kumari, KS Babu, P Haloi, ... Indian J Physiol Pharmacol 64 (1), 69-82, 2020 | 5 | 2020 |
| Phytochemical Loaded Nanovehicles of Biopolymer for Breast Cancer: A Systemic review VP Chavda, S Vuppu, R Bezbaruah, LV Nalla, SNR Gajula, PC Balar, ... Clinical Complementary Medicine and Pharmacology, 100114, 2023 | 4 | 2023 |
| Clinical Applications of “Omics” Technology as a Bioinformatic Tool V Chavda, R Bezbaruah, D Valu, S Desai, N Chauhan, S Marwadi, ... Bioinformatics Tools for Pharmaceutical Drug Product Development, 117-145, 2023 | 4 | 2023 |
| Lyotropic liquid crystalline phases: drug delivery and biomedical applications VP Chavda, S Dyawanapelly, S Dawre, I Ferreira-Faria, R Bezbaruah, ... International Journal of Pharmaceutics 647, 123546, 2023 | 3 | 2023 |
| Conjugated Nanoparticles for Solid Tumor Theranostics: Unraveling the Interplay of Known and Unknown Factors VP Chavda, PC Balar, LV Nalla, R Bezbaruah, NR Gogoi, SNR Gajula, ... ACS omega 8 (41), 37654-37684, 2023 | 3 | 2023 |
| Role of AI and ML in Epidemics and Pandemics R Bezbaruah, M Ghosh, S Kumari, L Nongrang, SR Ali, M Lahiri, H Waris, ... Bioinformatics Tools for Pharmaceutical Drug Product Development, 345-369, 2023 | 3 | 2023 |
